Holen Sie sich die Stockscreener-App
392.73
0.47%
-1.86
Vorhandelsmarkt:
393.76
1.03
+0.26%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt ELV?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$394.59
Offen:
$391
24-Stunden-Volumen:
930.75K
Relative Volume:
0.73
Marktkapitalisierung:
$85.17B
Einnahmen:
$201.11B
Nettoeinkommen (Verlust:
$4.95B
KGV:
17.46
EPS:
22.4991
Netto-Cashflow:
$6.29B
1W Leistung:
-2.41%
1M Leistung:
-0.43%
6M Leistung:
+37.13%
1J Leistung:
+22.85%
1-Tages-Spanne:
$390.00
$395.44
1-Wochen-Bereich:
$390.00
$405.13
52-Wochen-Spanne:
$274.84
$436.24
Elevance Health Inc Stock (ELV) Company Profile
Firmenname
Elevance Health Inc
Sektor
Branche
Telefon
(800) 331-1476
Adresse
220 VIRGINIA AVENUE, INDIANAPOLIS
Compare ELV vs UNH, CVS, CI, HUM
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ELV
Elevance Health Inc
|
392.73 | 85.90B | 201.11B | 4.95B | 6.29B | 22.50 |
UNH
Unitedhealth Group Inc
|
374.94 | 338.03B | 450.13B | 14.91B | 23.62B | 15.55 |
CVS
Cvs Health Corp
|
87.10 | 113.99B | 407.94B | 2.90B | 7.39B | 2.2771 |
CI
Cigna Group
|
275.26 | 71.88B | 278.13B | 6.74B | 7.66B | 23.60 |
HUM
Humana Inc
|
386.87 | 47.78B | 137.20B | 1.15B | 1.27B | 9.3439 |
Elevance Health Inc Stock (ELV) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-04-08 | Eingeleitet | Evercore ISI | In-line |
| 2026-02-03 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2026-01-08 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2025-12-19 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2025-10-14 | Eingeleitet | Goldman | Neutral |
| 2025-07-21 | Herabstufung | Argus | Buy → Hold |
| 2025-07-18 | Herabstufung | Leerink Partners | Outperform → Market Perform |
| 2025-04-15 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2025-03-17 | Hochstufung | Argus | Hold → Buy |
| 2025-01-22 | Herabstufung | Stephens | Overweight → Equal-Weight |
| 2024-10-18 | Herabstufung | Argus | Buy → Hold |
| 2024-07-18 | Herabstufung | BofA Securities | Buy → Neutral |
| 2024-06-24 | Eingeleitet | Morgan Stanley | Overweight |
| 2024-05-30 | Eingeleitet | Robert W. Baird | Outperform |
| 2024-03-06 | Eingeleitet | Barclays | Overweight |
| 2023-07-12 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2023-04-27 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2023-04-21 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2023-03-28 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2022-09-09 | Hochstufung | BofA Securities | Neutral → Buy |
| 2022-08-22 | Hochstufung | SVB Leerink | Mkt Perform → Outperform |
Alle ansehen
Elevance Health Inc Aktie (ELV) Neueste Nachrichten
The American Journal of Managed Care® announces Aaron L. Schwartz, M.D., Ph.D., as 2026 Emerging Leader in Managed Care Research Award recipient - GlobeNewswire Inc.
Elevance Health stock heads into the open after a 0.8 percent gain - AD HOC NEWS
Elevance Health stock carries a USD 27 adjusted EPS outlook - ad-hoc-news.de
AM Best withdraws ratings of Elevance Health's Hawaii captive - Captive Insurance Times
Elevance Health stock heads into the open after a 0.45 percent drop - ad-hoc-news.de
Elevance Health stock gains 2.1 percent on September 22 - ad-hoc-news.de
Elevance Health stock heads into the open after a 2.1 percent gain - ad-hoc-news.de
Elevance Health stock holds near its yearly high - ad-hoc-news.de
Elevance Health (ELV) Slips 0.80% to $410.95 as Shares Trade Between Key LevelsBPI Bull Correction - siam.in
Gail Boudreaux | Elevance Health CEO & Former Dartmouth Basketball Star - Britannica
Elevance Health stock gains as FY 2026 EPS guidance trails consensus - ad-hoc-news.de
Elevance Health (ELV) Stock May Be Below Fair Value As Guidance Was Reaffirmed - Yahoo Finance
Elevance Health stock gains as FY 2026 EPS guidance trails consensus slightly - AD HOC NEWS
Elevance Health (ELV) Q2 2026 Earnings Call Transcript - fortune.com
NY Surgeons Say Elevance Penalty Policy Is Anticompetitive - Law360
Elevance Health sued again over out-of-network penalty - Modern Healthcare
Can Carelon Drive Elevance Health's Future Earnings Growth? - Eastern Progress
Elevance Health Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Are Medical Stocks Lagging Elevance Health, Inc. (ELV) This Year? - Yahoo Finance
Elevance Health, Inc. (ELV) Stock forecasts - Yahoo Finance Australia
Why Does Elevance Health (NYSE:ELV) Matter in S&P 500? - Kalkine Media
Elevance leads UBS health benefits survey as employers brace for higher costs (ELV:NYSE) - Seeking Alpha
BofA Securities Adjusts Elevance Health Price Target to $480 From $460 - Moomoo
Elevance Health stock gains after reaffirmed 2026 earnings guidance - ad-hoc-news.de
Elevance Health Reaffirms 2026 Earnings and Cost Guidance - The Globe and Mail
Up 36% in the Last 12 Months, Does Elevance Health Stock Have More Room to Run Through 2028? - Yahoo Finance
ELV (Elevance Health) 5-Year EBITDA Growth Rate : 5.30% (As of Jun. 2026) - GuruFocus
Elevance Health Inc (ELV) Shares Surge 5.0% -- What GF Score of 90 Tells Investors - GuruFocus
ELV Stock Steadies As Oppenheimer Meeting Nears - StocksToTrade
Elevance Health Inc. stock outperforms competitors on strong trading day - MarketWatch
Should You Buy Elevance Health Stock For The Margin It Lost? - Trefis
Elevance Health reaffirms FY26 EPS guidance, shares rise 5% - scanx.trade
Elevance Health stock gains after 2026 earnings guidance is reaffirmed - ad-hoc-news.de
Elevance Health Stock is Moving Higher After FY26 EPS Reaffirmation - Benzinga
Why is Elevance Health stock surging today? By Investing.com - Investing.com Nigeria
Elevance Health Inc Stock (ELV) Moved Up by 5.50% on Sep 10: Drivers Behind the Movement - TradingKey
Elevance Health reaffirms 2026 earnings and benefit expense guidance By Investing.com - Investing.com South Africa
Elevance Health reaffirms 2026 earnings and benefit expense guidance - Investing.com
Form 8K Elevance Health Inc For: 10 September By Investing.com - Investing.com Nigeria
Elevance Health Gains as Investors Revisit Medicare Advantage Tailwinds - Quiver Quantitative
Elevance Health (ELV) Reaffirms 2026 Earnings Guidance of at Lea - GuruFocus
Elevance holds loss ratio guidance above 90% as fall renewals near - Insurance Business
Elevance Health at Wells Fargo conference: growth plan stays on track - Investing.com UK
Elevance Health Inc's Dividend Analysis - GuruFocus
Elevance Health (NYSE: ELV) sticks with its 2026 profit target - Stock Titan
Elevance Health Inc. stock outperforms competitors despite losses on the day - MarketWatch
Elevance Health stock falls amid sector worries over rising medical costs - ad-hoc-news.de
Bernstein Maintains Elevance Health(ELV.US) With Buy Rating, Maintains Target Price $488 - Moomoo
Elevance Health Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Elevance Health EVP and Chief Legal Officer Wessling Erin M Forfeits 349 Shares, Retains 7,230 Shares - Kalkine Media
2 Reasons to Watch ELV and 1 to Stay Cautious - Yahoo Finance
Finanzdaten der Elevance Health Inc-Aktie (ELV)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.26%
0.85%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):